Page last updated: 2024-11-02

moxonidine and Atrial Fibrillation

moxonidine has been researched along with Atrial Fibrillation in 2 studies

moxonidine: structure given in first source

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research Excerpts

ExcerptRelevanceReference
"Treatment with moxonidine is associated with less AF recurrences after ablation treatment for drug-refractory AF in patients with hypertension."5.19Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study. ( Deftereos, S; Doudoumis, K; Efremidis, M; Giannopoulos, G; Katsivas, A; Kossyvakis, C; Letsas, K; Manolis, AS; Panagopoulou, V; Pyrgakis, V; Raisakis, K; Rentoukas, I; Stefanadis, C; Tousoulis, D, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deftereos, S2
Giannopoulos, G2
Kossyvakis, C2
Efremidis, M2
Panagopoulou, V2
Raisakis, K2
Kaoukis, A1
Karageorgiou, S1
Bouras, G1
Katsivas, A2
Pyrgakis, V2
Stefanadis, C2
Doudoumis, K1
Letsas, K1
Rentoukas, I1
Manolis, AS1
Tousoulis, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Pharmacologic Suppression of Central Sympathetic Activity for Prevention of Atrial Fibrillation Recurrence After Pulmonary Vein Isolation (MOXAF)[NCT01791699]Phase 4150 participants (Anticipated)Interventional2012-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for moxonidine and Atrial Fibrillation

ArticleYear
Effectiveness of moxonidine to reduce atrial fibrillation burden in hypertensive patients.
    The American journal of cardiology, 2013, Sep-01, Volume: 112, Issue:5

    Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Convert

2013
Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study.
    Circulation, 2014, Oct-14, Volume: 130, Issue:16

    Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Catheter Ablation; Double-Blind Method; Female;

2014